American Century Companies Inc Supernus Pharmaceuticals, Inc. Transaction History
American Century Companies Inc
- $167 Billion
- Q3 2024
A detailed history of American Century Companies Inc transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 1,044,928 shares of SUPN stock, worth $37.2 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,044,928
Previous 501,658
108.29%
Holding current value
$37.2 Million
Previous $13.4 Million
142.79%
% of portfolio
0.02%
Previous 0.01%
Shares
27 transactions
Others Institutions Holding SUPN
# of Institutions
281Shares Held
60.6MCall Options Held
27.7KPut Options Held
11.3K-
Black Rock Inc. New York, NY10.4MShares$370 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.13MShares$218 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.1MShares$181 Million2.64% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$103 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$93.7 Million0.09% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.9B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...